Bleeding risk with bevacizumab - meta-analysis findings

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2011年 / 1345卷 / 1期
关键词：
Public Health; Carcinoma; Lung Cancer; Cell Carcinoma; Colorectal Cancer;
D O I：
10.2165/00128415-201113450-00012
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4 / 4
相关论文
共 50 条
  • [1] Risk of bleeding in cancer patients treated with the angiogenesis inhibitor bevacizumab: A meta-analysis
    Sher, A. F.
    Chu, D.
    Wu, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] Meta-Analysis of Rivaroxaban and Bleeding Risk
    Wasserlauf, Guila
    Grandi, Sonia M.
    Filion, Kristian B.
    Eisenberg, Mark J.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2013, 112 (03): : 454 - 460
  • [3] Risk of Bleeding in Hepatocellular Carcinoma Patients Treated with Atezolizumab/Bevacizumab: A Systematic Review and Meta-Analysis
    Song, Young-Gi
    Yeom, Kyeong-Min
    Jung, Eun Ae
    Kim, Sang Gyune
    Kim, Young Seok
    Yoo, Jeong-Ju
    [J]. LIVER CANCER, 2024,
  • [4] Venous thromboembolism and bleeding in cancer patients on bevacizumab therapy: a meta-analysis
    Kuderer, N. M.
    Ortel, T. L.
    Francis, C. W.
    Khorana, A. A.
    Poniewierski, M. S.
    Lyman, G. H.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 485 - 485
  • [5] Risk of high-grade bleeding in patients with cancer treated with bevacizumab: a meta-analysis of randomized controlled trials
    Hang, Xiao Feng
    Xu, Wen Sheng
    Wang, Jun Xue
    Wang, Lei
    Xin, Hai Guang
    Zhang, Rui Qi
    Ni, Wu
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 67 (06) : 613 - 623
  • [6] Risk of high-grade bleeding in patients with cancer treated with bevacizumab: a meta-analysis of randomized controlled trials
    Xiao Feng Hang
    Wen Sheng Xu
    Jun Xue Wang
    Lei Wang
    Hai Guang Xin
    Rui Qi Zhang
    Wu Ni
    [J]. European Journal of Clinical Pharmacology, 2011, 67 : 613 - 623
  • [7] Risk of bleeding associated with antiangiogenic monoclonal antibodies bevacizumab and ramucirumab: a meta-analysis of 85 randomized controlled trials
    Xiao, Bingkun
    Wang, Weilan
    Zhang, Dezhi
    [J]. ONCOTARGETS AND THERAPY, 2018, 11 : 5059 - 5074
  • [8] Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysis
    Hapani, Sanjaykumar
    Chu, David
    Wu, Shenhong
    [J]. LANCET ONCOLOGY, 2009, 10 (06): : 559 - 568
  • [9] Bevacizumab and risk of intracranial hemorrhage in patients with brain metastases: a meta-analysis
    Lin Yang
    Chuan-Jie Chen
    Xiao-Ling Guo
    Xiao-Cui Wu
    Bo-Jie Lv
    Hong-Li Wang
    Zhi Guo
    Xiang-Yang Zhao
    [J]. Journal of Neuro-Oncology, 2018, 137 : 49 - 56
  • [10] Increased Risk of Serious Hemorrhage with Bevacizumab in Cancer Patients: A Meta-Analysis
    Hapani, Sanjaykumar
    Sher, Amna
    Chu, David
    Wu, Shenhong
    [J]. ONCOLOGY, 2010, 79 (1-2) : 27 - 38
12345